Breakthrough infection of Trichosporon asahii in a patient with chronic lymphocytic leukemia.
Miura
Yasuo
Y
Department of Hematology, Osaka Red Cross Hospital, Osaka, Japan. ymiura@osaka-med.jrc.or.jp
Kaneko
Masahiko
M
Nishizawa
Masatoshi
M
Okamoto
Kohei
K
Hirai
Mihoko
M
Kaneko
Hitomi
H
Watanabe
Mitsumasa
M
Tsudo
Mitsuru
M
D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D000935:Antifungal Agents / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects; D000077723:Cefepime; D002511:Cephalosporins / Q000008:administration & dosage*; D003881:Dermatomycoses / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D006801:Humans; D017964:Itraconazole / Q000008:administration & dosage*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D017563:Lung Diseases, Interstitial / Q000139:chemically induced / Q000188:drug therapy / Q000382:microbiology; D008297:Male; D014250:Trichosporon
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D002511:Cephalosporins; D017964:Itraconazole; D000077723:Cefepime